How Satio is Revolutionizing Healthcare
Sapphiros has today completed the acquisition of Flexotronix Limited.
The partnership aims to enable low-cost access to vaccines and diagnostics to advance public health in Africa and beyond.
Satio and INTACT Solutions have entered into an agreement to establish a collaborative framework in order to partner on research, development, manufacture, and deployment of next generation health technologies with the goal of offering alternative solutions to traditional needles with SatioRx™ intradermal patches for the Member States of the African Union and beyond.
Technology that allows real-time, accurate detection of a wide range of specific targets, and delivers results within minutes.